Sahlgrenska University Hospital begins recruiting patients

Nov 6, 2024
1 min read

(November 6) Sahlgrenska University Hospital has started recruiting patients for the REDUSE trial. As one of Sweden's largest hospitals, Sahlgrenska University Hospital is a key contributor to medical research and innovation. The hospital's extensive experience in highly specialized care (including emergency and critical care) and close collaboration with the Sahlgrenska Academy at the University of Gothenburg makes it well-positioned to participate in and contribute valuable data to the REDUSE trial.

Recent Posts

See All

REDUSE hits 50% of patient recruitment target

(June 15) Last month, the REDUSE trial passed a significant milestone by reaching 50% of its target for patient inclusion. This major threshold is an exciting development, as it reflects the interest

Patient recruitment for REDUSE begins in Tampere, Finland

(May 25) Tammerfors University Hospital (Tays) in Tampere, Finland, became the second international site to commence patient recruitment for the REDUSE study. This exciting development comes just seve

Thesis defended by another REDUSE team member, Linn Hemberg

(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a

Comments